Skip to content
Review Open access

Short-chain fatty acid-producing commensals: Key modulators of AD neuroinflammation via the microbiota-gut-brain axis

Sep 2026 · Current Research in Microbial Sciences · Vol 11, pp. 100660 · 1 citation · 298 references
Medicine

TL;DR

Depletion of SCFA-producing gut bacteria is a consistent feature of Alzheimer’s disease across diverse populations and restoring SCFA-mediated gut-brain communication represents a promising disease-modifying strategy for early AD intervention.

Abstract

Highlights ● Depletion of SCFA-producing gut bacteria is a consistent feature of Alzheimer’s disease across diverse populations.● SCFAs suppress neuroinflammation via GPCR signaling, HDAC inhibition, and metabolic reprogramming of microglia and astrocytes.● SCFAs modulate Aβ deposition, tau pathology, and synaptic integrity through multi-layered regulatory mechanisms.● Restoring SCFA-mediated gut-brain communication represents a promising disease-modifying strategy for early AD intervention.

Read PDF

Similar papers

Review Sep 2026

Short-Chain Fatty Acids and FFAR2: Modulators of the Gut-Brain Axis in Neuroinflammatory Disorders.

Short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate, are key microbial metabolites generated through the fermentation of indigestible carbohydrates by gut bacteria. Beyond their local actions in the intestinal environment, these metabolites exert far-reaching systemic effects, particularly in s...

Harshpreet Kaur, Joy Das, A. Sah et al. · 0 citations
Review Sep 2026

Microbiota-derived metabolite-GPCR signalling in neurodegeneration.

By identifying convergent and disease-specific signalling pathways, the review highlights mechanistic nodes of therapeutic relevance and discusses GPCR-centric emerging and other microbiome-targeted strategies aimed at restoring metabolic and signalling homeostasis in neurodegenerative disorders.

Anshul Sharma, Nidhi Jatana · 0 citations
Review Open access Sep 2026

The gut microbiota-short-chain fatty acid-inflammation axis in Parkinson's disease motor dysfunction: mechanisms and future of dietary interventions

Parkinson's disease (PD) is a neurodegenerative disorder characterized mainly by motor dysfunction that severely affects quality of life. In recent years, the gut microbiota and its metabolites, short-chain fatty acids (SCFAs), have become a focus in PD research. These factors are proposed to influence disease progress...

Wan-Hong Wang, Wen-Yu Sun, Li-Hong Ma et al. · 0 citations
Review Sep 2026

The Gut-Brain Axis: Exploring the Role of Gut Microbiota in Alzheimer's Disease Pathogenesis and Therapeutics.

The gut microbiota acts as an upstream regulator of AD pathology through interconnected molecular mechanisms, and microbiota-targeted interventions have the potential to modulate these pathways and improve cognitive outcomes, although results vary across studies.

Javeria Fatima, Y. Siddique · 0 citations
Review Open access Aug 2026

The Gut Microbiome in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS whose risk and course are shaped by both genetic and environmental factors, among which the intestinal microbiota has emerged as a key, potentially modifiable contributor. People with MS frequently display altered gut microbiota, charact...

Alicia Sánchez-Sanz, S. Baranzini · 1 citation
Review Open access Aug 2026

Short-chain fatty acids as key mediators of the microbiota–gut–brain axis in chronic cerebral hypoperfusion: mechanisms and therapeutics

Chronic cerebral hypoperfusion (CCH) is an important contributor to vascular cognitive impairment and neurodegenerative disorders, characterized by neuronal injury, blood–brain barrier (BBB) disruption, neuroinflammation, mitochondrial dysfunction, and synaptic impairment. Increasing evidence suggests that the microbio...

Jun-Chen Si, Pei-Jian Wang, Zhong-Chen Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.